[1]
Millan Fachi, M., de Fátima Bonetti, A., Andrade Oliveira, L., Alves Oliveira Junior, H. e Camila Lucchetta, R. 2025. Cost-utility analysis of rhTSH for differentiated thyroid carcinoma from a societal perspective. JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA. 10, 4 (nov. 2025). DOI:https://doi.org/10.22563/2525-7323.2025.v10.e00257e.